Recalls / Active ingredient / Codeine Phosphate
Codeine Phosphate
6 FDA drug recalls involving the active ingredient “Codeine Phosphate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-01-07 | Class III | Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Phar | PAI Holdings, LLC. dba Pharmaceutical Associates Inc |
| 2020-03-18 | Class II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/60 mg, 100-count bottles, Rx Only, Distributed by: Au | Aurobindo Pharma USA Inc. |
| 2020-03-18 | Class II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Au | Aurobindo Pharma USA Inc. |
| 2020-03-18 | Class II | Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/15 mg, 100-count bottles, Rx Only, Distributed by: Au | Aurobindo Pharma USA Inc. |
| 2018-04-24 | Class II | Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for: | Prescript Pharmaceuticals, Inc. |
| 2017-12-12 | Class II | Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured For: Metho | Woodfield Pharmaceutical, LLC |